Avedro, Inc.

230 Third Avenue

Waltham, MA  02451

Tel: 781.768.3400


Leadership:
David Muller, Ph.D.
President & CEO


Website:
www.avedro.com

Avedro, Inc.

Flagship Partners:  David Berry
Initial Investment: 
2009
Status: 
Private

Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross‐linking and refractive correction. Avedro's products include capital equipment and related single dose pharmaceuticals. The KXL® System's cross‐linking, in combination with its pharmaceuticals, is used to treat keratoconus and corneal ectasia outside the United States. Those products are also used in a procedure known as Lasik Xtra®. Over 75,000 surgeries have been successfully performed outside the US using Avedro's KXL System.

David Berry is on the Board of Directors.